[Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines]

Urologe A. 2019 Sep;58(9):1029-1038. doi: 10.1007/s00120-019-0988-0.
[Article in German]

Abstract

The demographic developments of western society and the resulting increase in the number of very old patients in urology represents a challenge for the design of clinical studies and, consequently, recommendations of guidelines. While in internal medicine there is already a subspecialization with a focus on the treatment of elderly and multimorbid patients, in urology there is hardly any subspecialization into the problems of geriatric patients. Thus, using a case study as an example, the treatment decisions for benign prostatic hyperplasia (BPH) in geriatric patients are discussed. In addition the available evidence from the literature and guidelines are presented in order to assiste in daily management of geriatric patients with lower urinary tract symptoms and to critically discuss potential fields of application and limitations of the existing guidelines. In this context, we also examine the challenges when choosing a drug therapy and in deciding which of the many surgical options should be used.

Keywords: Anticoagulation; Benign prostatic hyperplasia; Geriatrics; Lower urinary tract symptoms; Prostate volume; Urinary urge incontinence.

Publication types

  • Review

MeSH terms

  • Aged
  • Humans
  • Lower Urinary Tract Symptoms / diagnosis*
  • Lower Urinary Tract Symptoms / etiology
  • Lower Urinary Tract Symptoms / therapy*
  • Male
  • Practice Guidelines as Topic*
  • Prostatic Hyperplasia / diagnosis*
  • Prostatic Hyperplasia / etiology
  • Prostatic Hyperplasia / therapy*
  • Urology / standards*